Interferon-γ production by T lymphocytes from renal cell carcinoma patients: Evidence of impaired secretion in response to interleukin-12

Journal of Immunotherapy

Volumn 22, Issue 1, 1999, Pages 71-79

  Ulchaker, James ^a   Panuto, John ^a   Rayman, Patricia ^a   Novick, Andrew ^a   Elson, Paul ^a,b   Tubbs, Raymond ^a   Finke, James H ^a,b   Bukowski, Ronald M ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Interferon ; Interleukin 12; Renal cell carcinoma; T lymphocytes

Indexed keywords

CD3 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; T LYMPHOCYTE RECEPTOR;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; INTERFERON INDUCTION; KIDNEY CARCINOMA; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

CARCINOMA, RENAL CELL; CELL SEPARATION; DNA; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-2; KIDNEY NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MUROMONAB-CD3; PHYTOHEMAGGLUTININS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0032951275     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-199901000-00010     Document Type: Article

References (33)

1. Kobayashi M, Fitz L, Ryan M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989; 170:827-45.
2. Stern AS, Podlaski FJ, Hulmes JD, et al. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human β-lymphoblastoid cells. Proc Natl Acad Sci USA 1990;87:6808-12.
3. Wolf SF, Temple PA, Kobayashi M, et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991;146:3074-81.
4. H1 cells. [Review] Immunol Today 1993;14:335-8.
5. Chan SH, Perussia B, Gupta JW, et al. Induction of Interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 1991;173:869-79.
6. Gately MK, Wolitzky AG, Quinn PM, Chizzonite R. Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol 1992;143:127-42.
7. Bertagnolli MM, Lin BY, Young D, Herrmann SH. IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J Immunol 1992;149:3778-83.
8. Gately MK, Desai BB, Wolitzky AG, et al. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 1991;147:874-82.
9. Gubler U, Chua AO, Schoenhaut DS, et al. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci USA 1991;88: 4143-7.
10. Roberston MJ, Soiffer RJ, Wolf SF, et al. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med 1992;175:779-88.
11. Itoh K, Platsoucas CD, Balch CM. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas: activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor. J Exp Med 1988;168:1419-41.
12. Finke JH, Rayman P, Hart L, et al. Characterization of tumor-infiltrating lymphocyte subsets from human renal cell carcinoma: specific reactivity defined by cytotoxicity, interferon γ secretion, and proliferation. J Immunother 1994;15:91-104.
13. Bukowski RM, Sharfman W, Murthy S, et al. Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma. Cancer Res 1991;51:4199-205.
14. Miescher S, Stoeck M, Qiao L, et al. Preferential clonogenic deficit of CD8-positive T-lymphocytes infiltrating human solid tumors. Cancer Res 1988;48:6992-8.
15. Miescher S, Stoeck M, Qiao L, Barras C, Barrelet L, Von Fliedner V. Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes: impaired response to mitogen-driven stimulation despite T-cell receptor expression. Int J Cancer 1988; 42:659-66.
16. Alexander JP, Kudoh S, Melsop KA, et al. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res 1993;53:1380-7.
17. 1ck in T-cells infiltrating human renal cell carcinoma. Cancer Res 1993;53:5613-6.
18. Hansel TT, De Vries IJ, Iff T, et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;145:105-10.
19. Sica D, Rayman, P, Stanley J, et al. Interleukin 7 enhances the proliferation and effector function of tumor-infiltrating lymphocytes from renal-cell carcinoma. Int J Cancer 1993;53:941-7.
20. Hollander M, Wolfe D, Nonparametric statistical methods. John New York: John Wiley, 1973.
21. Brunda MJ, Luistro L, Warrier RR, et al. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 1993;178:1223-30.
22. Tahara H, Zeh HJ 3rd, Storkus WJ, et al. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res 1994;54:182-9.
23. + T lymphocytes, and NK cells. J Immunol 1992;149:3495-502.
24. Chan SH, Kobayashi M, Santoli D, Perussia B, Trinchieri G. Mechanisms of INFγ induction by natural killer cell stimulatory factor (NKSF/IL-12): role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J Immunol 1992;148:92-8.
25. Andrews JV, Schoof DD, Bertagnolli MM, Peoples GE, Goedegebuure PS, Eberlein TJ. Immunomodulatory effects of interleukin-12 on human tumor-infiltrating lymphocytes. J Immunother 1993;14:1-10.
26. Zeh HJ 3rd, Hurd S, Storkus WJ, Lotze MT. Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer. J Immunother 1993;14:155-61.
27. Presky DH, Yang H, Minetti AD, et al. A functional interleukin-12 receptor complex is composed of two β type cytokine receptor subunits. Proc Natl Acad Sci USA 1996;93:14002-7.
28. Bacon CM, Mcvicar DW, Ortaldo JR, Rees RC, O'Shea JJ, Johnston JA. Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J Exp Med 1995;181:399-404.
29. Desai BB, Quinn PM, Wolitzky AG, Mongini PK, Chizzonite R, Gately MK. IL-12 receptor. II. Distribution and regulation of receptor expression. J Immunol 1992;148:3125-32.
30. Mills GB, Schmandt R, Gibson S, et al. Transmembrane signaling by the interleukin-2 receptor: progress and conundrums. Semin Immunol 1993;5:345-64.
31. Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell 1994;76:263-74.
32. Pignata C, Sanghera JS, Cossette L, Pelech SL, Ritz J. Interleukin-12 induces tyrosine phosphorylation and activation of 44-kD mitogen-activated protein kinase in human T cells. Blood 1994;83: 184-90.
33. Quill H, Bhandoola A, Trinchieri G, Haluskey J, Peritt D. Induction of interleukin 12 responsiveness is impaired in anergic T lymphocytes. J Exp Med 1994;179:1065-70.